Application 021337

Type
NDA
Sponsor
MERCK SHARP DOHME

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001INVANZERTAPENEM SODIUMINJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 1GM BASE/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021337-001INVANZERTAPENEM SODIUMEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N021337-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-211e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-218072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-215c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-215d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-214b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-2174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-2187673890dc5c…
2021-03-12 10:30 UTC2021-03N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-215aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-218869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-213f01610625f2…
2019-09-15 20:21 UTC2019-09N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21b00525d2431f…
2019-07-19 19:46 UTC2019-07N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-216a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-211c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-219b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-213f0d92c62455…
2023-05-13 08:27 UTC2023-05N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21053a50430f4f…
2023-01-26 05:58 UTC2023-01N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-213bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-213a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021337-001INVANZEQ 1GM BASE/VIALINJECTABLE / INTRAMUSCULAR, INTRAVENOUSAPRLD, RS2001-11-21cb3db0bc1861…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N021337-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021337-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N021337-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021337-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021337-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021337-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021337-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021337-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021337-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021337-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021337-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021337-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021337-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021337-001AP18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021337-001AP15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021337-001AP15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021337-001AP14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021337-001AP174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021337-001AP1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021337-001AP1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021337-001AP187673890dc5c…
2021-03-12 10:30 UTC2021-03N021337-001AP15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021337-001AP18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021337-001AP1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021337-001AP13f01610625f2…
2019-09-15 20:21 UTC2019-09N021337-001AP1b00525d2431f…
2019-07-19 19:46 UTC2019-07N021337-001AP1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021337-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021337-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021337-001AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021337-001AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021337-001AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021337-001AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021337-001AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05N021337-001AP1053a50430f4f…
2023-01-26 05:58 UTC2023-01N021337-001AP13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021337-001AP13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021337-001AP1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021337-001AP1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021337-001AP1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ERTAPENEMERTAPENEM SODIUMENDO USA, Inc.41304b1d-7db4-468a-ab1d-04e56fb50de42026-03-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 021337
application number: NDA021337
ndc (product): 42023-221
ERTAPENEMERTAPENEM SODIUMENDO USA, Inc.657855f2-7c92-4aa8-9c3d-51d08e56a09a2026-03-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 021337
application number: NDA021337
ndc (product): 42023-221
INVANZERTAPENEM SODIUMMerck Sharp & Dohme LLC33f3b99b-fa82-42e0-26bf-f49891ae3d222026-02-04Warnings, Adverse reactionsExact identifier
application applno (NDA): 021337
application number: NDA021337
ndc (product): 0006-3843

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 19 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme LLCNDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
0006-3843INVANZertapenem sodiumMerck Sharp & Dohme Corp.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent
42023-221ERTAPENEMertapenem sodiumPar Pharmaceutical Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
70564SUPPL2022-03-21
70555SUPPL2022-03-18
65754SUPPL2020-12-28
65714SUPPL2020-12-23
60172SUPPL2019-10-01
60089SUPPL2019-09-23
56939SUPPL2018-12-21
56895SUPPL2018-12-20
55524SUPPL2018-09-19
55480SUPPL2018-09-14
49809SUPPL2017-09-20
49727SUPPL2017-09-13
15216SUPPL2014-10-02
5081SUPPL2014-10-02
42107SUPPL2014-01-16
36689SUPPL2013-07-30
27515SUPPL2013-07-26
15215SUPPL2012-03-07
5080SUPPL2012-03-05
15214SUPPL2012-02-22
15211SUPPL2011-07-25
5078SUPPL2011-07-25
15213SUPPL2010-05-28
27514SUPPL2010-05-27
5077SUPPL2010-01-25
36688SUPPL2009-12-15
5079SUPPL2009-11-10
15212SUPPL2009-10-14
36687SUPPL2008-03-27
5076SUPPL2008-03-26
5075SUPPL2007-11-19
5074SUPPL2006-08-14
36686SUPPL2006-08-11
36685SUPPL2005-10-19
27513SUPPL2005-10-19
36684SUPPL2005-05-20
5073SUPPL2005-05-20
27512SUPPL2005-01-26
27511SUPPL2004-09-10
5072SUPPL2004-05-26
27510SUPPL2004-05-04
36683ORIG2001-11-09
21608ORIG2001-11-09
5071ORIG2001-11-09
51850ORIG1900-01-01
51849ORIG1900-01-01
51848ORIG1900-01-01
51847ORIG1900-01-01